Management change at Actelion

06-May-2014 - Switzerland

Actelion Ltd announced that Roland Haefeli, Senior Vice President, Head of Investor Relations and Public Affairs (IR & PA) and member of the Extended Actelion Executive Committee (AEC) has decided to step down from his current role for personal reasons effective 05 May 2014. Roland Haefeli will stay with Actelion in a senior advisory role.

Roland will hand over his position to Andrew Weiss, who joins Actelion from Bank Vontobel, where he was Head of Life Science Equity Research / Pharma Analyst.

Jean-Paul Clozel M.D. and Chief Executive Officer commented: "I am very pleased to welcome Andrew Weiss to Actelion as new Head of IR & CC and member of the Extended AEC. He brings an excellent understanding of the pharmaceutical market and a deep experience of the financial community. I am convinced that with his background and skills he will contribute to the future success of Actelion."

 

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances